On the relative risk of medical incapacity or impairment while driving Eric Schmedding.

Slides:



Advertisements
Similar presentations
Healthy life expectancy in the EU 15 Carol Jagger EHEMU team Europe Blanche XXVI Living Longer but Healthier lives Budapest November 2005.
Advertisements

Driving and Epilepsy – The IBE Perspective Driving and Epilepsy – The IBE Perspective Mike Glynn, IBE President 12 th Epilepsy and Society European Conference.
PRACTICE PARAMETER: RISK OF DRIVING AND ALZHEIMER ’ S DISEASE (AN EVIDENCE-BASED REVIEW) Richard M. Dubinsky, MD; Anthony C. Stein, PhD; and Kelly Lyons,
Study Project The Countries and Capitals of the European Union.
Understanding real research 3. Assessment of risk.
1 Safety education of pedestrian a systematic review O. Duperrex, F. Bunn, I. Roberts Sources of support: Institut de médecine sociale et préventive, Geneva,
Measures of association
Disability free Life Expectancy Carol Jagger University of Leicester EHEMU Team European Population Day: Ageing IUSSP Tours 2005.
Confronting “Death on Wheels” Making Roads Safe in the Europe and Central Asia Region (ECA) (May 12, 2010)
Brussels, 2 February 2010 “Curbing alcohol-related deaths on European roads” Antonio Avenoso Executive Director.
Incidence and Prevalence
1 ROAD SAFETY for SENIORS Presented by: Brian Everitt Manager – RACQ Driver Education Driver Safety Education & Training Logan Rd. Eight Mile Plains.
Climate Change Research Initiatives in EU Member States Side event: Research in response to the IPCC TAR 21 June, 2004, Bonn SB20 Dr. Frank McGovern, Ireland.
Kos September 2005Pr M.Samuelson1 Why do we need a European Forum for Primary Health care ? Is France concerned ? Marianne Samuelson Kos-Grece 2005.
Cohort Study.
Eurotransplant: An example of success for cross-border cooperation Bruno Meiser Eurotransplant International Foundation, Leiden, Netherlands Dept. of Cardiac.
1. Vehicle CrashesSuicides Falls Drownings Youth Violence Homicides Sports InjuriesBullying These are a few examples of a growing area in public health…
Dr Laura Bonnett Department of Biostatistics. UNDERSTANDING SURVIVAL ANALYSIS.
Visual Impairment, Age and Driving Chris Dickinson and Marliana Mahmud Department of Optometry and Neuroscience, UMIST.
Measures of Association
FONDE : A major new international research initiative (Marseille)
© International Road Transport Union (IRU) 2004 Page 1 The TØI Study “Taxi Regulation in Europe” Marc Billiet Head Passenger Transport IRU.
THE EUROPEAN UNION. HISTORY 28 European states after the second world war in 1951 head office: Brussels 24 different languages Austria joined 1995.
Sharps injuries among radiographers: Dangers associated with opening bottles of contrast agent Professor Gill Marshall Chair of Medical Imaging Education.
Using a driving simulator to identify older drivers at inflated risk of motor vehicle crashes Professor: Liu Student: Ruby.
Development of Standardized Descriptions of Driving Simulator Scenarios: The Older Driver 2005 TRB Human Factors Workshop Karlene Ball University of Alabama.
Age and Visual Impairment Decrease Driving Performance as Measured on a Closed-Road Circuit 學生:董瑩蟬.
1 Research methods and models of driver behavior studies.
Module 1 General introduction to substitution treatment.
SAVE-IT SAfety VEhicles using adaptive Interface Technology Phase 1 Research Program Quarterly Program Review Task 1: Scenario Identification Task Leader:
Biological Effects of Ionizing Radiation Stochastic Somatic Effects Radiation risk Lecture IAEA Post Graduate Educational Course Radiation Protection and.
1 Impact of methodological choices on road safety ranking SAMO conference: 20/06/07 Elke Hermans: Transportation.
AIECE GENERAL REPORT AUTUMN GENERAL MEETING Brussels, 7-8 November 2013.
Tim Wiemken PhD MPH CIC Assistant Professor Division of Infectious Diseases University of Louisville, Kentucky Confounding.
Texting and Driving Statistics.
Slide 1 Downloaded from Population Impact of Losartan Use on Stroke in the European Union (EU)
Horizon Scanning: future skills and competences of the health workforce in Europe MATT EDWARDS and JOHN FELLOWS WP6, EU JA on Health Workforce Planning.
The European Union 1 THE EUROPEAN UNION Lesson 2 Where in the world is the European Union?
Drink-Driving in the European Union SMART United Kingdom European Commission Representation, London Wednesday 14 th of October 2015 January 2015, Brussels.
Problem gambling in Europe: Why a regulatory authority needed Dr Mark Griffiths Professor of Gambling Studies International Gaming Research Unit
Assessing status and trends of birds in the European Union: Assessing status and trends of birds in the European Union: Reviewing methods and experience.
Information and communicationDirectorate general for Energy and Transport Medril Workshop Brussels, 25 November 2005 Impact of medical conditions on road.
Assessing fitness to drive in Category B licence holders in Great Britain Dr Heather Major Senior Medical Adviser DVLA Swansea
What are the Chances Dr? Nick Pendleton. Can I have a Prostate Check? ?
MEDRIL workshop 2: The medical condition of the category B driving population Hotel Eurovillage, Brussels 25 November 2005 MEDRIL MEDical testing for the.
Information and communicationDirectorate general for Energy and Transport Medril Workshop Brussels, 25 November 2005 Driving licence and fitness to drive.
Comenius Project Mobility & Transport Of Hille and Stella from Tallinn school of Economic and Of Svenja, Simone and Kristin from the KBS Bayreuth.
Public Health Needs and Priorities of the new EU Strategy on Alcohol “Alcohol in all policies - Roadmap for action at the EU level” workshop 6th European.
Methodological quality assessment of observational studies Nicole Vogelzangs Department of Psychiatry & EMGO + institute.
Understanding Populations & Samples
#YDF2017.
Dr Wyn Parry Senior Medical Adviser DVLA
Driving and texting has become the most distracted driving for multiple people especially for teenagers. “Pride is a wonderful, terrible thing, a seed.
Rome Cardiology Forum 2014 Update on life-style and cardiovascular prevention The dimension of the problem Rome Cardiology Forum January 29, 2014.
Achieving WHO Recommendations for HCV in the European Union
Hypothesis Testing.
Elderly driver safety in Switzerland – current reality and future perspectives VII. International Conference on European Traffic Policies, 10th & 11th.
Dr. Benoît ESNAULT (CRE) and Dr. Stefanie NEVELING (BNetzA)
8. Causality assessment:
ETSC_PIN_Talk_Estonia_2010_21_May
Cannabis and driving: regulations, drug testing and (future) science
Selection of cities Anastasios Maroudas Eurogramme
EU: First- & Second-Generation Immigrants
General Delegate Euro Contrôle Route
ESBACE – EUROPEAN STUDY ON THE BURDEN AND CARE OF EPILEPSY
Digital Health Literacy: A brief overview of the IC-Health project
Limiting risks, protecting lives Choices for novice drivers and their passengers Prepared 22/12/08.
EU commission Rose, So Eun.
Where in the world is the European Union?
Prodcom Statistics in Focus
Presentation transcript:

On the relative risk of medical incapacity or impairment while driving Eric Schmedding

Brussels, 25 nov 2005Second MEDRIL workshop Content Two types of risk and one criterium Two types of risk and one criterium Relative Risk in the assessment of incapacity: epilepsy Relative Risk in the assessment of incapacity: epilepsy The equation of risk for incapacity The equation of risk for incapacity Relationship between RR and COSY Relationship between RR and COSY Difference for the assessment of impairment: vision Difference for the assessment of impairment: vision Relative Risk: why use it ? Relative Risk: why use it ? What if…? – no theory What if…? – no theory

Brussels, 25 nov 2005Second MEDRIL workshop Second Working Group on Epilepsy and Driving of the European Union: members Mr Joël Valmain Mr Joël Valmain Dr Jaume Burcet Darde Dr Jaume Burcet Darde Dr Bernhard Gappmaier Dr Bernhard Gappmaier Prof Guenter Kraemer Prof Guenter Kraemer Dr John Kirker Dr John Kirker Dr Mikael Ojala Dr Mikael Ojala Dr Nicole Markschies Dr Nicole Markschies Dr Eric Schmedding Dr Eric Schmedding Dr Anders Sundqvist Dr Anders Sundqvist Dr Elena Valdès Dr Elena Valdès Prof Hervé Vespigniani, Prof Hervé Vespigniani, Dr Graham Wetherall Dr Graham Wetherall Dr Jörgen Worm-Petersen Dr Jörgen Worm-Petersen Traffic Bureau EU Traffic Bureau EU Spain Spain Austria Austria Germany Germany Ireland Ireland Finland Finland Germany Germany Belgium Belgium Sweden Sweden Spain Spain France France United Kingdom United Kingdom Denmark Denmark

Brussels, 25 nov 2005Second MEDRIL workshop Criteria for two types of risks ? For the population: For the population: “A” attributable risk A = The % of the population at risk because of the disease * ( R – 1 ) A = The % of the population at risk because of the disease * ( R – 1 ) A = P ( R – 1 ) A = P ( R – 1 ) For the driver: For the driver: “R” relative risk R = a ratio of risks: The risk of people with the disease / the risk of people without the disease The risk for the population remains low as long as "R" is reasonable

Brussels, 25 nov 2005Second MEDRIL workshop A = Attributable risk A = Attributable risk A = P ( R – 1 )P = 0.6*70% A = P ( R – 1 )P = 0.6*70% A = 0.42 ( 2.0 – 1 ) = 0.42 % A = 0.42 ( 2.0 – 1 ) = 0.42 % RR-1 RR P (no epilepsy) P (no epilepsy) Total population with a licence Total population with a licence “A”: Risk for the population

Brussels, 25 nov 2005Second MEDRIL workshop How much is 0.42% ? European Union 2001 accidents per million European Union 2001 accidents per million Injury- accidents 3400 Injury- accidents 3400 Serious (+ fatal) accidents 710 Serious (+ fatal) accidents 710 So 0.42% would be:3 serious So 0.42% would be:3 serious including0.4 fatal

Brussels, 25 nov 2005Second MEDRIL workshop “R”: who runs the risk? > 60% of the risk is for the driver Europe: 61% of all fatalities are drivers Europe: 61% of all fatalities are drivers USA:68% USA:68% the remaining risk shared by the passengers > = other road users the remaining risk shared by the passengers > = other road users driverspassengers others driverspassengers others 60% ca 25%ca15% 60% ca 25%ca15% If passengers are present, the risk for them rises up to the driver´s level !

Brussels, 25 nov 2005Second MEDRIL workshop The quest for a criterium -population level There are few data (but none from Europe) about the risk for the individual driver with epilepsy but theoretically the risk is low for the population There are few data (but none from Europe) about the risk for the individual driver with epilepsy but theoretically the risk is low for the population

Brussels, 25 nov 2005Second MEDRIL workshop Two types of risks For the population: For the population: “A” attributable risk A = The % of the population at risk because of the disease * ( R – 1 ) A = The % of the population at risk because of the disease * ( R – 1 ) A = P ( R – 1 ) A = P ( R – 1 ) For the driver: For the driver: “R” relative risk R = a ratio of risks: The risk of people with the disease / the risk of people without the disease The risk for the population remains low as long as "R" is reasonable A "R" of 2-3 is very acceptable and should not lead to inability to drive

Brussels, 25 nov 2005Second MEDRIL workshop Acceptable for epilepsy ?

Brussels, 25 nov 2005Second MEDRIL workshop The quest for a criterium -driver level The criterium for driving should be based on the risk for the patient, rather than on the risk for the population The criterium for driving should be based on the risk for the patient, rather than on the risk for the population Relative risks up to 3 (6?) are accepted for some groups within the population Relative risks up to 3 (6?) are accepted for some groups within the population Relative risks of 2 – 4 could be acceptable for patients Relative risks of 2 – 4 could be acceptable for patients

The quest for a criterium The relation between the Relative Risk and the COSY RR 2 – 3 is COSY 20% - 40% COSY = Chance of an Occurrence of a Seizure in the next Year Incapacity: epilepsy

Brussels, 25 nov 2005Second MEDRIL workshop Factors in the equation of risk 1. exposure acute/chronic impairment 2. acute incapacity 3. accident 4. Outcome (fatalities) r = (R-1).F/(DX) DrXFDrXF

Brussels, 25 nov 2005Second MEDRIL workshop Factors in the equation of risk 1. D = 0.04 acute/chronic impairment 2. COSY = 20% (r = 0.2) 3. X = F = r = (R-1).F/(DX) DrXFDrXF

Brussels, 25 nov 2005Second MEDRIL workshop Factors in the equation of risk r = (R-1).F/(DX) 4. F = D = 0.04 acute/chronic impairment 2. COSY = 20% (r = 0.2) 3. X = 0.6 D r X F From the COSY to the personal risk increase: R F/(DX) = r = COSY (in %) /100 R = individual risk ratio (compared to someone who does not have epilepsy) F = fatal casualty rate per driver per year (1 / 7250 drivers) in the population D = proportion of time spent at the wheel (1 hour = 0.042) X = probability of a seizure at the wheel leading to a fatality (0.6*0.03 = 0.018) COSY = 2% R = 1.1 COSY = 10%R = 1.5 COSY = 20%R = 2.1 COSY = 30%R = 2.6 COSY = 40%R = 3.2

Recurrence risk The COSY decreases with the length of the seizure-free period

Brussels, 25 nov 2005Second MEDRIL workshop Model for the next occurrence of a randomly occurring event Criterium line

Brussels, 25 nov 2005Second MEDRIL workshop Recurrence before seizure-free period 3 mo 6 mo 12 mo 3 mo Relative Risk23

Brussels, 25 nov 2005Second MEDRIL workshop Recurrence after seizure-free period 3 mo 6 mo 12 mo 3 mo X mo 3 mo Europe Cosy 20% = RR 2.1 Relative Risk23

Brussels, 25 nov 2005Second MEDRIL workshop Different approach: the use of RR Impairment Impairment Identification of the relevant Identification of the relevant functions functions RR per function and per RR per function and per impairment category impairment category Cut-off value (e.g. RR > 2 ? ) Cut-off value (e.g. RR > 2 ? ) Test Test function while driving Confounding variables Importance of adaptive behaviour Measurement instruments Robust? Reproducible? Face value? "cheat resistance"? Incapacity Incapacity How likely is it to occur while driving? You need the co-operation of the patient Determine the COSY Compare with the criterium Calculation Calculation

Brussels, 25 nov 2005Second MEDRIL workshop Impairment: the use of RR Impairment Impairment Identification of the relevant functions Identification of the relevant functions RR per function and per impairment category RR per function and per impairment category Cut-off value (e.g. RR > 2 ? ) Cut-off value (e.g. RR > 2 ? ). range

Brussels, 25 nov 2005Second MEDRIL workshop

Brussels, 25 nov 2005Second MEDRIL workshop Epilepsy: what´s in a word? Chance of having an accident Chance of having an accident Not increased in the group that is allowed to drive (OR: 0.95 CI: ) Not increased in the group that is allowed to drive (OR: 0.95 CI: ) Taylor, Chadwick, Johnson: “Risk of accidents in drivers with epilepsy” J Neurol, Neurosurg, Psychiatry 1996; 60: Taylor, Chadwick, Johnson: “Risk of accidents in drivers with epilepsy” J Neurol, Neurosurg, Psychiatry 1996; 60: Hugely increased in a pre-surgical group (frequent seizures) of 367 patients: 40 % at some point had a seizure while driving Hugely increased in a pre-surgical group (frequent seizures) of 367 patients: 40 % at some point had a seizure while driving 70 % of them (27% of the whole group) had, at one point in time, one or more accidents while driving. Of these 32% had physical damage themselves; 20% caused physical damage in others 70 % of them (27% of the whole group) had, at one point in time, one or more accidents while driving. Of these 32% had physical damage themselves; 20% caused physical damage in others Berg A et al: “Driving in adults with refractory localisation-related epilepsy” Neurology 2000; 54: Berg A et al: “Driving in adults with refractory localisation-related epilepsy” Neurology 2000; 54:

Brussels, 25 nov 2005Second MEDRIL workshop Relative risk useful? Find RR not for groups (diseases), but for factors that influence driving Find RR not for groups (diseases), but for factors that influence driving Incapacity, e.g. Epilepsy: Incapacity, e.g. Epilepsy: COSY COSY Impairment, e.g. Vision: functions Impairment, e.g. Vision: functions Visual acuity RR<2 Visual acuity RR<2 contrast sensitivity contrast sensitivity glare sensitivity (= condition- dependent) glare sensitivity (= condition- dependent) visual field (binocular test) (UFOV) visual field (binocular test) (UFOV) diplopia… diplopia… Research

Brussels, 25 nov 2005Second MEDRIL workshop The rules as proposed for epilepsy group 2 are based on a COSY of 2%The rules as proposed for epilepsy group 2 are based on a COSY of 2% Driving time: times 5 Toll of accidents:times 3 Assessment: what to do with… Multiple RR´s Multiple RR´s Comorbidity or the side-effect of medication Comorbidity or the side-effect of medication Limited licence Limited licence No consistent advice on how to use it No consistent advice on how to use it Group 2 Group 2 More severe, but how? More severe, but how? 15 times as severe

Brussels, 25 nov 2005Second MEDRIL workshop Conclusions To find a criterium of acceptable risk, we should consider the risk for the person (RR), not the risk for the population (A, attributable risk) To find a criterium of acceptable risk, we should consider the risk for the person (RR), not the risk for the population (A, attributable risk) An "RR" of 2-3 is acceptable An "RR" of 2-3 is acceptable RR does not give the increase in risk compared to the population ! RR does not give the increase in risk compared to the population ! RR when studied in medical conditions for non- homogeneous groups is not usable as such. The RR has to be studied for well-defined subgroups RR when studied in medical conditions for non- homogeneous groups is not usable as such. The RR has to be studied for well-defined subgroups RR is usefull RR is usefull As criterium in risk assessment For reasons of consistency In explanation and thus motivation of the patient

Brussels, 25 nov 2005Second MEDRIL workshop No theory… …means no adequate scientific data …means no adequate scientific data For the chance of a period of incapacity in the next year (COSY) For the chance of a period of incapacity in the next year (COSY) For the RR of a certain function and a specific impairment category For the RR of a certain function and a specific impairment category …means no criterium for "non-disease" ( = no necessity to test or assess) …means no criterium for "non-disease" ( = no necessity to test or assess) …but will the theory be proven to be an improvement on common sense ?

Second MEDRIL workshop Brussels, 25 november 2005